Results 1 to 10 of about 3,746,463 (320)

Factors Associated With The Initiation Of Biologic Disease Modifying Antirheumatic Drugs In Texas Medicaid Patients With Rheumatoid Arthritis [PDF]

, 2014
G. Kim, Jamie C. Barner, KL Rascati, Kristin M. Richards   +3 more
openalex   +1 more source

Withdrawal of disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a systematic review and meta-analysis

, 2009
Rachel O’Mahony, Mark Richards, C. Deighton, D. G. I. Scott   +3 more
openalex   +1 more source

Phase III, multicenter, open-label, long-term study of the safety of abatacept in Japanese patients with rheumatoid arthritis and an inadequate response to conventional or biologic disease-modifying antirheumatic drugs [PDF]

, 2014
Tsutomu Takeuchi, Tsukasa Matsubara, Yukitomo Urata, Eiichi Suematsu, Shuji Ohta, Shigeru Honjo, Tohru Abe, Ami Yamamoto, Nobuyuki Miyasaka   +8 more
openalex   +1 more source

Lipid profiles in rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs [PDF]

, 2014
Anna Filipowicz‐Sosnowska, Piotr Głuszko, Robert Rupiński   +2 more
openalex   +1 more source

Facilitators and Barriers to Adherence in the Initiation Phase of Disease-modifying Antirheumatic Drug (DMARD) Use in Patients with Arthritis Who Recently Started Their First DMARD Treatment [PDF]

, 2014
Annelieke Pasma, Adriaan van ’t Spijker, Jolanda J. Luime, Margot Walter, Jan J.V. Busschbach, Johanna M W Hazes   +5 more
openalex   +1 more source

Management of Rheumatoid Arthritis Patients with Interstitial Lung Disease: Safety of Biological Antirheumatic Drugs and Assessment of Pulmonary Fibrosis [PDF]

, 2015
Shunsuke Mori
openalex   +1 more source

Changes to the Australian Pharmaceutical Benefit Scheme restrictions for biological disease‐modifying antirheumatic drugs have influenced the use of leflunomide [PDF]

, 2015
Ashley M. Hopkins, Agnès Vitry, Catherine O’Doherty, Susanna Proudman, Michael D. Wiese   +4 more
openalex   +1 more source

Serum nitric oxide and peroxynitrite levels in adult sero-positive rheumatoid arthritis treated with disease modifying antirheumatic drugs: a preliminary report

, 2010
Marwan S.M. Al-Nimer, SAMIR ABDUL-HASSAN AL-OBAIDI, KHALID S. AL-DULAIMI   +2 more
openalex   +2 more sources

A Case of Oral Mucous Membrane Ulcers Caused by Disease-modifying Antirheumatic Drug (DMARD; Bucillamine)

, 2011
角田 愛美, 荒関 昭博, 高橋 悦子   +2 more
openalex   +2 more sources

Faculty Opinions recommendation of Persistence of antibody response 1.5 years after vaccination using 7-valent pneumococcal conjugate vaccine in patients with arthritis treated with different antirheumatic drugs.

, 2013
Direk Limmathurotsakul, Cherry Lim
openalex   +2 more sources